8. Genetics & Molecular Diagnostics

Progen Diagnostics · UK Market Access
Introducing Innovation · Opportunity 03

Genetics & Molecular Diagnostics

We see significant opportunity to make molecular diagnostics faster, simpler and more accessible.

Molecular
Diagnostics
01 Faster testing
02 Greater access
03 Simpler workflows
04 Clinical value
Technology
Progen Diagnostics
UK healthcare
01 · The opportunity

Make advanced molecular testing practical, scalable and valuable.

Genetics and molecular diagnostics are becoming increasingly important across cancer, inherited disease, infectious disease and personalised medicine. The opportunity is not simply to provide more sophisticated testing, but to make it practical, scalable and valuable within routine healthcare.

Scientists analysing genomic and molecular diagnostic data
The opportunity Make advanced molecular testing faster, simpler and more accessible in routine healthcare.
02 · Where we're looking

Molecular technologies with potential for routine clinical use.

01 PCR & digital PCR
02 Next-generation sequencing
03 Genotyping
04 Biomarkers
05 Liquid biopsy
06 Pharmacogenomics
07 Companion diagnostics
08 Sample preparation
09 Rapid molecular testing
10 Workflow automation
Automated molecular diagnostic testing and laboratory workflow
Automation · Molecular workflow From sample to result
03 · What interests us

Proven molecular technology with a clear advantage.

We are looking for proven molecular technologies that can move testing closer to routine clinical practice and demonstrate a clear advantage over existing approaches.

Improve sensitivity or specificity
Reduce turnaround time
Simplify workflows
Reduce cost per test
Increase testing capacity
Enable targeted treatment
Extend access to molecular testing
Molecular diagnostic technology route into UK healthcare
PROGEN DIAGNOSTICS Turn technical capability into a UK healthcare proposition.
01 Faster answers
02 Simpler workflows
03 Greater access
Have a technology that fits?

Turn molecular capability into a proposition relevant to UK healthcare.

We can help translate technical capability into a proposition relevant to UK laboratories, clinicians and healthcare decision-makers — and provide the route to establish it in the market.

Talk to us about your technology →